Literature DB >> 30122451

A Hotspot for Disease-Associated Variants of Human PGM1 Is Associated with Impaired Ligand Binding and Loop Dynamics.

Kyle M Stiers1, Lesa J Beamer2.   

Abstract

Human phosphoglucomutase 1 (PGM1) plays a central role in cellular glucose homeostasis, catalyzing the conversion of glucose 1-phosphate and glucose 6-phosphate. Recently, missense variants of this enzyme were identified as causing an inborn error of metabolism, PGM1 deficiency, with features of a glycogen storage disease and a congenital disorder of glycosylation. Previous studies of selected PGM1 variants have revealed various mechanisms for enzyme dysfunction, including regions of structural disorder and side-chain rearrangements within the active site. Here, we examine variants within a substrate-binding loop in domain 4 (D4) of PGM1 that cause extreme impairment of activity. Biochemical, structural, and computational studies demonstrate multiple detrimental impacts resulting from these variants, including loss of conserved ligand-binding interactions and reduced mobility of the D4 loop, due to perturbation of its conformational ensemble. These potentially synergistic effects make this conserved ligand-binding loop a hotspot for disease-related variants in PGM1 and related enzymes.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  X-ray crystallography; conformational ensemble; enzyme; inherited disease; loop mobility; missense variants; molecular dynamics

Mesh:

Substances:

Year:  2018        PMID: 30122451      PMCID: PMC6314294          DOI: 10.1016/j.str.2018.07.005

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  49 in total

1.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

2.  GROMACS: fast, flexible, and free.

Authors:  David Van Der Spoel; Erik Lindahl; Berk Hess; Gerrit Groenhof; Alan E Mark; Herman J C Berendsen
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

3.  Loss of protein structure stability as a major causative factor in monogenic disease.

Authors:  Peng Yue; Zhaolong Li; John Moult
Journal:  J Mol Biol       Date:  2005-10-21       Impact factor: 5.469

Review 4.  Stability effects of mutations and protein evolvability.

Authors:  Nobuhiko Tokuriki; Dan S Tawfik
Journal:  Curr Opin Struct Biol       Date:  2009-09-16       Impact factor: 6.809

5.  Osmolyte-induced conformational changes in the Hsp90 molecular chaperone.

Authors:  Timothy O Street; Kristin A Krukenberg; Jörg Rosgen; D Wayne Bolen; David A Agard
Journal:  Protein Sci       Date:  2010-01       Impact factor: 6.725

6.  A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene.

Authors:  Belén Pérez; Celia Medrano; Maria Jesus Ecay; Pedro Ruiz-Sala; Mercedes Martínez-Pardo; Magdalena Ugarte; Celia Pérez-Cerdá
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

7.  Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient.

Authors:  Nina Ondruskova; Tomas Honzik; Alzbeta Vondrackova; Marketa Tesarova; Jiri Zeman; Hana Hansikova
Journal:  Neuro Endocrinol Lett       Date:  2014       Impact factor: 0.765

Review 8.  Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function.

Authors:  Lesa J Beamer
Journal:  J Inherit Metab Dis       Date:  2014-08-29       Impact factor: 4.982

9.  Multiple phenotypes in phosphoglucomutase 1 deficiency.

Authors:  Laura C Tegtmeyer; Stephan Rust; Monique van Scherpenzeel; Bobby G Ng; Marie-Estelle Losfeld; Sharita Timal; Kimiyo Raymond; Ping He; Mie Ichikawa; Joris Veltman; Karin Huijben; Yoon S Shin; Vandana Sharma; Maciej Adamowicz; Martin Lammens; Janine Reunert; Anika Witten; Esther Schrapers; Gert Matthijs; Jaak Jaeken; Daisy Rymen; Tanya Stojkovic; Pascal Laforêt; François Petit; Olivier Aumaître; Elzbieta Czarnowska; Monique Piraud; Teodor Podskarbi; Charles A Stanley; Reuben Matalon; Patricie Burda; Soraya Seyyedi; Volker Debus; Piotr Socha; Jolanta Sykut-Cegielska; Francjan van Spronsen; Linda de Meirleir; Pietro Vajro; Terry DeClue; Can Ficicioglu; Yoshinao Wada; Ron A Wevers; Dieter Vanderschaeghe; Nico Callewaert; Ralph Fingerhut; Emile van Schaftingen; Hudson H Freeze; Eva Morava; Dirk J Lefeber; Thorsten Marquardt
Journal:  N Engl J Med       Date:  2014-02-06       Impact factor: 91.245

10.  Changes in Lysozyme Flexibility upon Mutation Are Frequent, Large and Long-Ranged.

Authors:  Deeptak Verma; Donald J Jacobs; Dennis R Livesay
Journal:  PLoS Comput Biol       Date:  2012-03-01       Impact factor: 4.475

View more
  7 in total

1.  Two forms of phosphomannomutase in gammaproteobacteria: The overlooked membrane-bound form of AlgC is required for twitching motility of Lysobacter enzymogenes.

Authors:  Guoliang Qian; Shifang Fei; Michael Y Galperin
Journal:  Environ Microbiol       Date:  2019-05-23       Impact factor: 5.491

2.  Effects of the T337M and G391V disease-related variants on human phosphoglucomutase 1: structural disruptions large and small.

Authors:  Kyle M Stiers; Luckio F Owuocha; Lesa J Beamer
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2022-04-25       Impact factor: 1.072

3.  Genetic validation of Aspergillus fumigatus phosphoglucomutase as a viable therapeutic target in invasive aspergillosis.

Authors:  Kaizhou Yan; Mathew Stanley; Bartosz Kowalski; Olawale G Raimi; Andrew T Ferenbach; Pingzhen Wei; Wenxia Fang; Daan M F van Aalten
Journal:  J Biol Chem       Date:  2022-04-30       Impact factor: 5.486

4.  N-Glycosylation influences human corticosteroid-binding globulin measurements.

Authors:  Lesley A Hill; Zeynep Sumer-Bayraktar; John G Lewis; Eva Morava; Morten Thaysen-Andersen; Geoffrey L Hammond
Journal:  Endocr Connect       Date:  2019-08       Impact factor: 3.335

5.  Evolutionary rescue of phosphomannomutase deficiency in yeast models of human disease.

Authors:  Ryan C Vignogna; Mariateresa Allocca; Maria Monticelli; Joy W Norris; Richard Steet; Ethan O Perlstein; Giuseppina Andreotti; Gregory I Lang
Journal:  Elife       Date:  2022-10-10       Impact factor: 8.713

6.  PSCAN: Spatial scan tests guided by protein structures improve complex disease gene discovery and signal variant detection.

Authors:  Zheng-Zheng Tang; Gregory R Sliwoski; Guanhua Chen; Bowen Jin; William S Bush; Bingshan Li; John A Capra
Journal:  Genome Biol       Date:  2020-08-26       Impact factor: 13.583

7.  Structural basis for substrate and product recognition in human phosphoglucomutase-1 (PGM1) isoform 2, a member of the α-D-phosphohexomutase superfamily.

Authors:  Paul Hoff Backe; Jon K Laerdahl; Lene Svendsen Kittelsen; Bjørn Dalhus; Lars Mørkrid; Magnar Bjørås
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.